Premier Membership: Live Stock Trade Alerts to Buy & Sell with JoeThis is where the majority of our members come to. FOR $99/month or $799 (1 installment) you become a member of an exclusive group of traders wanting to tap into this powerful resource on a daily, if not hourly, basis. In addition to the educational videos, weeknight market recaps, […]
Stock Trading Alert: New Downtrend Or Just Another Pull-Back? No Clear Direction So FarBy: Paul Rejczak | Mon, Apr 20, 2015SharePrintEmailStock Trading Alert originally published on April 20, 2015, 6:43 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): neutralMedium-term outlook […]
Stock Trading Alert: Stocks Fluctuate As Investors Await Earnings Reports Releases – Which Direction Is Next?By: Paul Rejczak | Thu, Apr 9, 2015SharePrintEmailStock Trading Alert originally published on April 9, 2015, 6:17 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 […]
Stock Trading Alert: Positive Expectations As Investors Bet On ReversalBy: Paul Rejczak | Mon, Mar 30, 2015SharePrintEmailStock Trading Alert originally published on March 30, 2015, 6:30 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): neutralMedium-term outlook (next 1-3 months): […]
Stock Trading Alert: Stocks Sold Off And Retraced Last Week’s Advance, Will They Continue Down?By: Paul Rejczak | Thu, Mar 26, 2015SharePrintEmailStock Trading Alert originally published on March 26, 2015, 7:30 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook is now neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): […]
Swing trading falls between short-term intraday trading and long-term fundamental-based investing. Swing traders hold a specific position for a few days or weeks expecting price momentum, cyclic, or trend reversal patterns to materialize. The focus is not on the fundamental or intrinsic value of a stock, but rather on price trends and patterns over a shorter term.Swing trading requires timely […]
Here’s how to protect your profits in biotech: Trader
Susquehanna’s Stacey Gilbert thinks biotech could be due for a pullback. She lays out an options strategy to protect your biotech holdings.
It’s been a record-breaking run for biotech stocks, with the Nasdaq Biotech ETF, the IBB, up 18 percent this year alone and nearly 300 percent in the past five years. But […]
Here’s how to protect your profits in biotech: Trader
Susquehanna’s Stacey Gilbert thinks biotech could be due for a pullback. She lays out an options strategy to protect your biotech holdings.
It’s been a record-breaking run for biotech stocks, with the Nasdaq Biotech ETF, the IBB, up 18 percent this year alone and nearly 300 percent in the past five years. But […]
Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]
KITE Flying High! KITE, JUNO, BLCM, BLUEShares of Kite Pharma, Inc. (KITE) popped nearly +16% today, afterthe company announced acquisition of a privately held Netherlands-based biotechnology company, T-Cell Factory B.V. This may not have been the only reason. Juno Therapeutics (JUNO) said today that it expects to have 10 product candidates in clinical development directed at six different cancer-associated antigens. […]
